Avanos Medical, Inc. (AVNS)

Jul 27, 2026 - AVNS was delisted (reason: acquired by American Industrial Partners)

+0.01 (0.04%)

Inactive · Last trade price on Jul 24, 2026

Avanos Medical Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	715.9	701.2	687.8	673.3	684.1	587
Revenue Growth	3.87%	1.95%	2.15%	-1.58%	16.54%	-17.88%
Gross Profit	358.3	353.9	381.3	379.7	394.2	299.2
Operating Income	-74.5	-61.6	-396.2	4.2	35.5	-39
Net Income	5.1	72.9	392.1	61.8	-50.5	-6.3
Earnings Per Share	-1.61	-1.57	-8.53	-1.32	1.07	-0.64
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Pain Management and Recovery (pm&r)	237.9	237.8	234.2
Specialty Nutrition Systems (sns)	455.8	432.9	396.4
Corporate and Other	22.2	30.5	57.2
Total	715.9	701.2	687.8

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	65.6	89.8	107.7	87.7	127.7	118.5
Total Debt	138.4	129.1	170.2	209.1	277	187.5
Net Cash (Debt)	-72.8	-39.3	-62.5	-121.4	-149.3	-69
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.56	-0.85	-1.36	-2.61	-3.16	-1.42

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	36.7	74.7	100.7	32.4	90.9	87.3
Capital Expenditures	-29.2	-31.6	-17.8	-17.8	-19.3	-21
Free Cash Flow	7.5	43.1	82.9	14.6	71.6	66.3
Free Cash Flow Growth	-93.42%	-48.01%	467.81%	-79.61%	7.99%	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	50.05%	50.47%	55.44%	56.39%	57.62%	50.97%
Operating Margin	-10.41%	-8.78%	-57.60%	0.62%	5.19%	-6.64%
Pretax Margin	-10.77%	-9.44%	-58.64%	-1.17%	3.90%	-7.17%
Profit Margin	-10.77%	-10.40%	-56.16%	-1.47%	3.14%	-5.26%
FCF Margin	1.05%	6.15%	12.05%	2.17%	10.47%	11.29%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	25.29	-
Forward PE	21.73	11.70	10.10	15.65	15.89	23.16
P/FCF Ratio	156.10	12.10	8.83	70.94	17.58	25.21
PS Ratio	1.64	0.74	1.06	1.54	1.84	2.85